Critical tests evaluating efficacy of moxidectin against small strongyles in horses from a herd for which reduced activity had been found in field tests in Central Kentucky (original) (raw)

Abstract

Critical tests were performed in 2009 and 2010 in four 2-year-old horses naturally infected with internal parasites. The horses were from a herd (Farm MC) where reduced activity of ivermectin and moxidectin on small strongyles was demonstrated previously from EPG (eggs/gram of feces) data in field tests. Also, in critical tests in horses from the same herd, ivermectin was less effective on immature small strongyles in the lumen of the large intestine than when the drug was first marketed. The main interest in the present critical tests was to determine the efficacy of moxidectin (400 μg/kg) on small strongyles. This was done to try and find indications of why there has been a return of strongyle EPG counts sooner after treatment in field tests than when moxidectin was first commercially available. Removal of adult small strongyles for the four treated horses was >99% to 100%. Efficacy on immature (L4) small strongyles was 82%, 96%, 98%, and >99% for the individual horses. Identification of small strongyles recovered from two of the horses revealed that three genera and 11 species were present. Specimens of Cylicocyclus ashworthi are reported for the first time in horses in Kentucky although eggs of this species have been identified. Moxidectin, in the present study, was excellent on removing adult small strongyles but was less effective on immatures (L4) in the intestinal contents. The question as to why moxidectin efficacy on small strongyles has declined in field tests may have been answered at least to a certain extent. It seems that a significant factor is “quick development” of a few remaining immatures in the gut lumen of horses. Also, possible activity may have decreased on encysted stages in the large intestinal lining. In any event, after treatment of some horses with moxidectin, the life cycle of small strongyles is shorter now than at the onset of usage of this compound.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

The alternative text for this image may have been generated using AI.

Fig. 2

The alternative text for this image may have been generated using AI.

Fig. 3

The alternative text for this image may have been generated using AI.

Similar content being viewed by others

References

Download references

Acknowledgments

This investigation (Paper No. 10-14-068) was made in connection with a project of the University of Kentucky Agricultural Experiment Station and is published with the approval of the director. Appreciation is expressed to the Albert and Lorraine Clay Fellowship for partial financial support for one of the authors, Tetiana Kuzmina, to come as a visiting scientist from the Ukraine to the University of Kentucky to study parasites of equids.

Author information

Authors and Affiliations

  1. Department of Veterinary Science, Gluck Equine Research Center, University of Kentucky, Lexington, KY, 40546-0099, USA
    Eugene T. Lyons, Sharon C. Tolliver & Sandra S. Collins
  2. Institute of Zoology, NAS of Ukraine, vul. B. Khmelnyts’kogo, 15, Kyiv, Ukraine , 01601
    Tetiana A. Kuzmina

Authors

  1. Eugene T. Lyons
  2. Sharon C. Tolliver
  3. Tetiana A. Kuzmina
  4. Sandra S. Collins

Corresponding author

Correspondence toEugene T. Lyons.

Rights and permissions

About this article

Cite this article

Lyons, E.T., Tolliver, S.C., Kuzmina, T.A. et al. Critical tests evaluating efficacy of moxidectin against small strongyles in horses from a herd for which reduced activity had been found in field tests in Central Kentucky.Parasitol Res 107, 1495–1498 (2010). https://doi.org/10.1007/s00436-010-2025-5

Download citation

Keywords